DAL MONTE, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 7.667
EU - Europa 3.673
AS - Asia 1.265
AF - Africa 238
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
Totale 12.858
Nazione #
US - Stati Uniti d'America 7.450
IT - Italia 1.605
CN - Cina 645
SE - Svezia 645
BG - Bulgaria 378
CA - Canada 215
DE - Germania 197
UA - Ucraina 194
SG - Singapore 179
GB - Regno Unito 147
VN - Vietnam 134
CI - Costa d'Avorio 125
FI - Finlandia 118
TR - Turchia 99
AT - Austria 84
CH - Svizzera 62
FR - Francia 61
IN - India 60
NG - Nigeria 60
HK - Hong Kong 56
RU - Federazione Russa 51
BE - Belgio 39
ID - Indonesia 28
EG - Egitto 25
SN - Senegal 21
CZ - Repubblica Ceca 17
JP - Giappone 16
AL - Albania 11
NL - Olanda 10
PL - Polonia 9
SA - Arabia Saudita 9
ES - Italia 8
HU - Ungheria 8
IL - Israele 8
DK - Danimarca 7
KR - Corea 7
PH - Filippine 7
AU - Australia 6
GR - Grecia 6
IE - Irlanda 6
EU - Europa 4
KE - Kenya 4
AE - Emirati Arabi Uniti 3
MU - Mauritius 3
NP - Nepal 3
PT - Portogallo 3
NZ - Nuova Zelanda 2
PK - Pakistan 2
PS - Palestinian Territory 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
AM - Armenia 1
BR - Brasile 1
BS - Bahamas 1
EE - Estonia 1
LT - Lituania 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
VE - Venezuela 1
Totale 12.858
Città #
Fairfield 947
Woodbridge 860
Chandler 705
Houston 622
Ann Arbor 515
Ashburn 502
Seattle 380
Sofia 378
Milan 353
Serra 336
Wilmington 321
Cambridge 317
Beijing 253
New York 246
Ottawa 203
Jacksonville 181
Princeton 178
Lawrence 146
Medford 132
Abidjan 125
Des Moines 115
Nanjing 108
Izmir 86
Vienna 75
Singapore 73
Bern 59
Florence 57
Lagos 57
San Diego 57
Hong Kong 56
Dong Ket 54
Los Angeles 54
Falls Church 49
Dearborn 47
Nanchang 45
London 39
Pisa 38
Boulder 37
Brussels 36
Rome 35
Kunming 34
Redwood City 34
Jüchen 33
Chicago 32
Frankfurt am Main 30
Marseille 28
Washington 23
Dakar 21
Livorno 21
Hefei 20
Ogden 20
Shenyang 20
Alessandria 19
Changsha 19
Norwalk 19
Napoli 18
Hebei 17
Boardman 16
Pune 16
Brno 15
Catania 15
Hangzhou 15
Lancaster 15
Bari 14
Auburn Hills 12
Jiaxing 12
Tianjin 12
Cairo 11
Viareggio 10
Jeddah 9
Jinan 9
Lappeenranta 9
Shanghai 9
Jakarta 8
Lucca 8
Scuola 8
Al Mansurah 7
Bremen 7
Dallas 7
Guangzhou 7
Massa 7
Mumbai 7
Surabaya 7
Capannori 6
Indiana 6
Many 6
Grafing 5
Kilburn 5
Modena 5
Orange 5
Phoenix 5
San Giuliano Terme 5
Warsaw 5
Cerreto Guidi 4
Chongqing 4
Cyców 4
Fuzhou 4
Kent 4
Renton 4
San Francisco 4
Totale 9.638
Nome #
Dexamethasone Improves Ofloxacin Efficacy in Treating Acute Bacterial Conjunctivitis: Evidence from A Rabbit Model 245
Nanoparticle-Mediated Delivery of Neuroprotective Substances for the Treatment of Diabetic Retinopathy 177
Autophagy-mediated neuroprotection induced by octreotide in an ex vivo model of early diabetic retinopathy 174
Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer 155
Diabetic retinopathy: Neuroprotection as a therapeutic target 147
Agonisti selettivi dei recettori beta-adrenergici di tipo 3 (BAR3) e loro impiego 143
Altered morphology of rod bipolar cell axonal terminals in the retinas of mice carrying genetic deletion of somatostatin subtype receptor 1 or 2 135
Exposure to extreme climatic environments reduces circulating endothelial progenitor cells. 134
S-thiolation mechanisms of aldose reductase 133
VEGF as a survival factor in ex vivo models of early diabetic retinopathy 133
A new approach against sugar cataract through aldose reductase inhibitors 132
Lisosan G Protects the Retina from Neurovascular Damage in Experimental Diabetic Retinopathy 132
In vitro and in vivo inhibition of proangiogenic retinal phenotype by an antisense oligonucleotide downregulating uPAR expression 129
Somatostatin (SRIF) and SRIF receptors in the mouse retina 127
Potential role of the methylation of VEGF gene promoter in response to hypoxia in oxygen-induced retinopathy: beneficial effect of the absence of AQP4 125
Zofenoprilat-Glutathione mixed disulfide as a specific S-thiolating agent of bovine lens aldose reductase 118
β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function 117
The Urokinase Receptor-Derived Peptide UPARANT Recovers Dysfunctional Electroretinogram and Blood–Retinal Barrier Leakage in a Rat Model of Diabetes 117
Prooxidative action of cysteine in the glutathione-mediated oxidative modification of lens aldose reductase 115
The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization 115
Antiangiogenic role of miR-361 in human umbilical vein endothelial cells: functional interaction with the peptide somatostatin 114
Role of host β1- and β2-adrenergic receptors in a murine model of B16 melanoma: functional involvement of β3-adrenergic receptors 114
Efficacy of fatty acids dietary supplement in polyethylene glycol-induced mouse model of retinal degeneration 113
Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity 113
Modulation of aldose reductase activity through S-thiolation by physiological thiols 112
Lens glutathione S-transferase as a catalyst of transthiolation processes 110
Neurokinin 1 receptor expression and substance P physiological actions are developmentally regulated in the rabbit retina 109
Adenylyl cyclase/cAMP system involvement in the antiangiogenic effect of somatostatin in the retina. Results from transgenic mice 109
Acetyl-11-keto--boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy 107
Specifically targeted modification of human aldose reductase by physiological disulfides 106
Expression, localization, and functional coupling of the somatostatin receptor subtype 2 in a mouse model of oxygen-induced retinopathy 105
Involvement of cysteine residues in glutathione dependent modification of human aldose reductase 104
Coenzyme Q10 instilled as eye drops on the cornea reaches the retina and protects retinal layers from apoptosis in a mouse model of kainate-induced retinal damage 104
Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants 104
The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases 104
Vascular Endothelial Growth Factor in the Ischemic Retina and Its Regulation by Somatostatin 103
Thiol/disulfide interconversion in bovine lens aldose reductase induced by intermediates of glutathione turnover 103
The Beta Adrenergic Receptor Blocker Propranolol Counteracts Retinal Dysfunction in a Mouse Model of Oxygen Induced Retinopathy: Restoring the Balance Between Apoptosis and Autophagy 103
Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System 103
Glio-vascular modifications caused by Aquaporin-4 deletion in the mouse retina 102
Antiangiogenic role of somatostatin receptor 2 in a model of hypoxia-induced neovascularization in the retina: results from transgenic mice 102
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial. 101
Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis 101
Alpha-crystallin acting as a molecular chaperone in preventing thermal induced denaturation of bovine lens sorbitol dehydrogenase 100
Indirect blockade of vascular endothelial growth factor: the potential for eye disease therapy 100
Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin. 99
Somatostatin coupling to adenylyl cyclase activity in the mouse retina 99
Association of the Somatostatin Analog Octreotide With Magnetic Nanoparticles for Intraocular Delivery: A Possible Approach for the Treatment of Diabetic Retinopathy 99
Purification and characterization of two odorant binding proteins from nasal tissue of rabbit and pig 98
Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy. 98
Coenzyme Q10 protects retinal cells from apoptosis induced by radiation in vitro and in vivo 97
Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia 96
The pathophisiology of retinopathy of prematurity: an update of previous and recent knowledge 96
GLUTATHIONE-MODIFIED ALDOSE REDUCTASE IN OXIDATIVELY STRESSED BOVINE LENS 95
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial 95
Oral Propranolol for Retinopathy of Prematurity: Risks, Safety Concerns, and Perspectives 95
β3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells 95
Effects of Somatostatin Analogues on Retinal Angiogenesis in a Mouse Model of Oxygen-Induced Retinopathy: Involvement of the Somatostatin Receptor Subtype 2 93
SITE-SPECIFIC OXIDATION OF BOVINE LENS ALDOSE REDUCTASE INDUCED BY COPPER-ION 92
Novel Insights into Beta 2 Adrenergic Receptor Function in the rd10 Model of Retinitis Pigmentosa 91
Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP) 91
Chaperone-like activity of alpha-crystallin against thermal denaturation of sorbitol dehydrogenase 90
Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices 90
Expression of Substance P, Neurokinin 1 receptors (NK1)and Neurokinin 3 receptors in the developing mouse retina and in the retina of NK1 knock out mice 90
Reversibility of S-thiolation of aldose reductase in intact bovine lens undergoing oxidative stress 89
Functional correlates of somatostatin receptor 2 over-expression in the retina of mice with genetic deletion of somatostatin receptor 1 88
Identification of BRAF 3'UTR Isoforms in Melanoma. 88
Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission 88
Localization patterns of fibroblast growth factor 1 and its receptors FGFR1 and FGFR2 in postnatal mouse retina 87
Anti-angiogenic effectiveness of the urokinase receptor-derived peptide UPARANT in a model of oxygen induced retinopathy 87
Activation of the Thiazide-Sensitive Sodium-Chloride Cotransporter by Beta3-Adrenoreceptor in the Distal Convoluted Tubule. 87
S-Thiolation of enzymes as a defence mechanism against oxidative stress 86
β3 adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling. 85
High molecular weight hepatotrophic-scatter factors released in serum-free medium by the coltured embryo rat fibroblastic cell line FRL 85
A Dietary Combination of Forskolin with Homotaurine, Spearmint and B Vitamins Protects Injured Retinal Ganglion Cells in a Rodent Model of Hypertensive Glaucoma 85
Mechanisms underlying somatostatin receptor 2 downregulation of vascular endothelial growth factor expression in response to hypoxia in mouse retinal explants 84
Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis. 84
BINDING OF SELECTED ODORANTS TO BOVINE AND PORCINE ODORANT-BINDING PROTEINS 80
Interconversion pathways of aldose reductase induced by thiol compounds 79
The urokinase-type plasminogen activator system as drug target in retinitis pigmentosa: New pre-clinical evidence in the rd10 mouse model 79
Therapeutic Potential of Anti-Angiogenic Multi-Target N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy. 78
UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis 78
Cysteinylglycine hydrolase activity in bovine lens 77
Interconversion pathways of aldose reductase induced by thiol compounds 77
Solid phase enzyme immunoassay for the Odorant Binding Protein (OBP) 76
Site-specific inactivation of aldose reductase by 4-hydroxynonenal. 76
Involvement of the cAMP-dependent pathway in the reduction of epileptiform bursting caused by somatostatin in the mouse hippocampus 75
Thioltransferase activity of bovine lens glutathione S-transferase. 75
β3 -Adrenoceptor as a potential immuno-suppressor agent in melanoma. 75
Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization 74
Propranolol concentrations after oral administration in term and preterm neonates 74
Inactivation of bovine lens aldose reductase by 4-hydroxynonenal 72
Signalling potential and protein modifying ability of physiological thiols 72
Relationships Between Neurodegeneration and Vascular Damage in Diabetic Retinopathy 70
Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the beta-adrenergic system 69
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study 68
Modificazione glutatione dipendente dell'aldoso reduttasi del cristallino: un modello di studio del danno proteico indotto da stress ossidativo 67
The aldose reductase inhibitor ARI509 as a potentially effective drug for a long term cyclic therapy against diabetic cataract 67
Somatostatin inhibits potassium-evoked glutamate release by activation of the sst(2) somatostatin receptor in the mouse retina 67
Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy 67
Totale 10.063
Categoria #
all - tutte 37.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.229


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.401 266 212 152 140 229 278 280 200 261 168 140 75
2020/20211.391 91 84 144 104 143 82 85 124 98 123 112 201
2021/20221.904 75 142 65 93 295 299 72 95 113 59 113 483
2022/20232.278 249 280 131 187 263 307 25 156 519 16 123 22
2023/20241.776 179 171 216 125 293 324 58 63 37 72 51 187
2024/202547 47 0 0 0 0 0 0 0 0 0 0 0
Totale 13.339